Why cachexia kills: Examining the causality of poor outcomes in wasting conditions

Journal of Cachexia, Sarcopenia and Muscle

Volumn 4, Issue 2, 2013, Pages 89-94

  Kalantar Zadeh, Kamyar ^a,e   Rhee, Connie ^a   Sim, John J ^f   Stenvinkel, Peter ^d,h   Anker, Stefan D ^g   Kovesdy, Csaba P ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Kaiser Permanente of Southern California ^*  (United States)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arrhythmias; Cachexia; Cause of death; Infection; Platelet activation

Indexed keywords

ACTIN; ADIPONECTIN; ENDOTOXIN; GELSOLIN; INTERLEUKIN 10; THYROID HORMONE;

ADIPOSE TISSUE; ANDROGEN DEFICIENCY; ANEMIA; BODY MASS; CACHEXIA; CHRONIC KIDNEY DISEASE; EDITORIAL; ENDOCRINE DISEASE; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPOTHYROIDISM; IRON DEFICIENCY; KIDNEY FAILURE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; SARCOPENIA; SUDDEN DEATH; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOSIS; WASTING SYNDROME; WEIGHT REDUCTION;

EID: 84879232016     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-013-0111-0     Document Type: Editorial

References (18)

1. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27: 793-9.
2. Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013. doi: 10. 1007/s13539-013-0105-y.
3. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58: 295-300.
4. Kovesdy CP, Kalantar-Zadeh K. Observational studies versus randomized controlled trials: avenues to causal inference in nephrology. Adv Chronic Kidney Dis. 2012;19: 11-8.
5. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95: S144-50.
6. Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, et al. High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr. 2011;94: 945-54.
7. Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008;52: 727-36.
8. Keung YK, Owen J. Iron deficiency and thrombosis: literature review. Clin Appl Thromb Hemost. 2004;10: 387-91.
9. Beyan C, Kaptan K. Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto's thyroiditis. Blood Coagul Fibrinolysis. 2013. doi: 10. 1097/MBC. 0b013e32836069f5.
10. Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, et al. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol. 2009;20: 1140-8.
11. Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol. 2009;29: 3-14.
12. Webb JG, Kiess MC, Chan-Yan CC. Malnutrition and the heart. CMAJ. 1986;135: 753-8.
13. Doehner W, Anker SD. Beta blockers and glucose metabolism in chronic heart failure: friend or foe? Clin Res Cardiol. 2008;97: 21-3.
14. Rauchhaus M, Koloczek V, Volk H, Kemp M, Niebauer J, Francis DP, et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000;76: 125-33.
15. Sandek A, Bjarnason I, Volk HD, Crane R, Meddings JB, Niebauer J, et al. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol. 2012;157: 80-5.
16. Pedroso FE, Spalding PB, Cheung MC, Yang R, Gutierrez JC, Bonetto A, et al. Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia. J Cachexia Sarcopenia Muscle. 2012;3: 199-211.
17. Tschirner A, von Haehling S, Palus S, Doehner W, Anker SD, Springer J. Ursodeoxycholic acid treatment in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2012;3: 31-6.
18. Utech AE, Tadros EM, Hayes TG, Garcia JM. Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers. J Cachexia Sarcopenia Muscle. 2012;3: 245-51.